Array Biopharma
Array, Pierre Fabre bowel cancer therapy ‘could replace chemo’
Phil Taylor
Array Biopharma, colorectal cancer, Oncology, Pfizer, Pierre Fabre
0 Comment
X
Array, Pierre Fabre bowel cancer therapy ‘could replace chemo’
https://pharmaphorum.com/news/array-pierre-fabre-bowel-cancer-therapy-could-replace-chemo/
As Lyrica patent expiry looms, Pfizer buys Array for $11.4bn
Phil Taylor
Array Biopharma, cancer, M&A, melanoma, Pfizer
0 Comment
X
As Lyrica patent expiry looms, Pfizer buys Array for $11.4bn
https://pharmaphorum.com/news/as-lyrica-patent-expiry-looms-pfizer-buys-array-for-11-4bn/
ASCO-contributor/ Market Access/ Oncology/ Partner content/ Partner Content/ Partner Content/ Pharma Market Access/ Press releases
Does NEMO bring us a step closer in the fight against melanoma?
Len Kusdra and Jay Grisolano
Array Biopharma, asco, immunotherapy, kantar health, metastatic melanoma, NRAS, Oncology, Pharmaceuticals
0 Comment
X
Does NEMO bring us a step closer in the fight against melanoma?
https://pharmaphorum.com/partner-content-oncology/nemo-bring-us-step-closer-fight-melanoma/